- Published on:
Washington, Aug 24 (Prensa Latina) A new therapeutic strategy could avoid chemotherapy in early breast cancer (HER-2+) and thus reduce toxicity associated with its treatment, the American Society of Clinical Oncology said on Wednesday.
